CollPlant Biotechnologies CLGN
NASDAQ CLGN
$4.12 +0.09 (+2.23%)
At close: Nov 9, 2026 · 4:00 PM EST

CollPlant Biotechnologies (CLGN) Change in Acquisitions & Divestments (2022)

Updated

CollPlant Biotechnologies' Change in Acquisitions & Divestments came in at -$20 million for the quarter ended Dec 31, 2022, compared with -$30 million a year earlier.

Analysis

CollPlant Biotechnologies (CLGN) Change in Acquisitions & Divestments (2022) Analysis & Trends

  • Going back by year, Change in Acquisitions & Divestments was -$30 million in the year ended Dec 31, 2021 and -$166,000 in the year ended Dec 31, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 CollPlant Biotechnologies 4.98 Mn -17.38 Mn -456,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 30.19 Mn
API Access

CollPlant Biotechnologies Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=CLGN&period=max&api_key=YOUR_API_KEY